The decrease in the pathological changes on hepatic steatosis and levels of AST, ALT, TG, TCHO and LDL/VLDL in plasma, as well as an increase of plasma HDL in the diabetic mice fed CP extract-supplemented diets, in comparison with the diabetic model group indicates a potent hepatoprotective effect of CP extract. The gene discussed is CP; the disease is Hepatic steatosis.